Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akouos, Inc. stock logo
AKUS
Akouos
$13.29
$13.29
$2.32
$13.60
$490.88M-0.55344,411 shs440 shs
BioSpecifics Technologies Corp. stock logo
BSTC
BioSpecifics Technologies
$88.53
$88.47
$42.00
$89.15
$650.25M0.2461,105 shsN/A
Eagle Pharmaceuticals, Inc. stock logo
EGRX
Eagle Pharmaceuticals
$4.38
-3.7%
$5.47
$4.10
$30.40
$56.90M0.41215,326 shs18,475 shs
Emisphere Technologies, Inc. stock logo
EMIS
Emisphere Technologies
$7.81
$7.81
$4.06
$9.16
N/AN/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$18.02
+0.6%
$20.17
$16.90
$36.64
$504.20M1.6217,435 shs38,417 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akouos, Inc. stock logo
AKUS
Akouos
0.00%0.00%0.00%0.00%0.00%
BioSpecifics Technologies Corp. stock logo
BSTC
BioSpecifics Technologies
0.00%0.00%0.00%0.00%0.00%
Eagle Pharmaceuticals, Inc. stock logo
EGRX
Eagle Pharmaceuticals
-4.61%+3.64%-10.43%-14.15%-83.48%
Emisphere Technologies, Inc. stock logo
EMIS
Emisphere Technologies
0.00%0.00%0.00%0.00%0.00%
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
+1.53%-1.70%-6.13%-32.03%-39.27%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Akouos, Inc. stock logo
AKUS
Akouos
N/AN/AN/AN/AN/AN/AN/AN/A
BioSpecifics Technologies Corp. stock logo
BSTC
BioSpecifics Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Eagle Pharmaceuticals, Inc. stock logo
EGRX
Eagle Pharmaceuticals
3.7927 of 5 stars
2.51.00.03.92.03.31.9
Emisphere Technologies, Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
1.7311 of 5 stars
0.03.01.72.62.31.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akouos, Inc. stock logo
AKUS
Akouos
N/AN/AN/AN/A
BioSpecifics Technologies Corp. stock logo
BSTC
BioSpecifics Technologies
N/AN/AN/AN/A
Eagle Pharmaceuticals, Inc. stock logo
EGRX
Eagle Pharmaceuticals
1.00
Sell$17.00288.13% Upside
Emisphere Technologies, Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
1.00
SellN/AN/A

Current Analyst Ratings

Latest RDUS, EMIS, EGRX, BSTC, and AKUS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/28/2024
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Sell
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akouos, Inc. stock logo
AKUS
Akouos
N/AN/AN/AN/A$4.90 per shareN/A
BioSpecifics Technologies Corp. stock logo
BSTC
BioSpecifics Technologies
$38.19M17.03$3.38 per share26.18$18.42 per share4.81
Eagle Pharmaceuticals, Inc. stock logo
EGRX
Eagle Pharmaceuticals
$316.61M0.18$3.48 per share1.26$17.94 per share0.24
Emisphere Technologies, Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$2.88B0.17$4.22 per share4.27$30.29 per share0.59

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akouos, Inc. stock logo
AKUS
Akouos
-$86.67M-$2.62N/AN/AN/AN/A-45.09%-36.86%N/A
BioSpecifics Technologies Corp. stock logo
BSTC
BioSpecifics Technologies
$24.47M$3.3337.5117.60N/A47.43%14.81%14.46%N/A
Eagle Pharmaceuticals, Inc. stock logo
EGRX
Eagle Pharmaceuticals
$35.64M$1.183.71N/AN/AN/AN/A5/14/2024 (Estimated)
Emisphere Technologies, Inc. stock logo
EMIS
Emisphere Technologies
N/AN/A0.00N/AN/AN/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
-$25.79M-$2.28N/A19.80N/A-2.28%-1.73%-0.88%6/25/2024 (Estimated)

Latest RDUS, EMIS, EGRX, BSTC, and AKUS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/4/2024Q2 2024
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
-$1.09-$1.04+$0.05-$0.89$626.35 million$621.06 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Akouos, Inc. stock logo
AKUS
Akouos
N/AN/AN/AN/AN/A
BioSpecifics Technologies Corp. stock logo
BSTC
BioSpecifics Technologies
N/AN/AN/AN/AN/A
Eagle Pharmaceuticals, Inc. stock logo
EGRX
Eagle Pharmaceuticals
N/AN/AN/AN/AN/A
Emisphere Technologies, Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$0.754.16%N/AN/A N/A

Latest RDUS, EMIS, EGRX, BSTC, and AKUS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/1/2024
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
quarterly$0.18753.7%4/19/20244/22/20245/6/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akouos, Inc. stock logo
AKUS
Akouos
N/A
17.30
17.30
BioSpecifics Technologies Corp. stock logo
BSTC
BioSpecifics Technologies
N/A
66.24
66.24
Eagle Pharmaceuticals, Inc. stock logo
EGRX
Eagle Pharmaceuticals
N/AN/AN/A
Emisphere Technologies, Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
0.43
1.96
0.92

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Akouos, Inc. stock logo
AKUS
Akouos
10336.94 million35.16 millionNot Optionable
BioSpecifics Technologies Corp. stock logo
BSTC
BioSpecifics Technologies
77.35 millionN/ANot Optionable
Eagle Pharmaceuticals, Inc. stock logo
EGRX
Eagle Pharmaceuticals
13412.99 million9.23 millionOptionable
Emisphere Technologies, Inc. stock logo
EMIS
Emisphere Technologies
6N/AN/ANot Optionable
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
3,35327.98 million26.39 millionOptionable

RDUS, EMIS, EGRX, BSTC, and AKUS Headlines

SourceHeadline
Radius Recycling (NASDAQ:RDUS) Upgraded by StockNews.com to "Hold"Radius Recycling (NASDAQ:RDUS) Upgraded by StockNews.com to "Hold"
americanbankingnews.com - April 25 at 5:27 AM
Radius Recycling (NASDAQ:RDUS) Upgraded by StockNews.com to HoldRadius Recycling (NASDAQ:RDUS) Upgraded by StockNews.com to Hold
marketbeat.com - April 24 at 11:24 PM
Radius Recycling (NASDAQ:RDUS) Shares Gap Up to $17.43Radius Recycling (NASDAQ:RDUS) Shares Gap Up to $17.43
marketbeat.com - April 17 at 1:11 PM
Radius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal DiseasesRadius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
finance.yahoo.com - April 16 at 9:27 AM
Radius Recycling (NASDAQ:RDUS) Shares Up 3.6%Radius Recycling (NASDAQ:RDUS) Shares Up 3.6%
marketbeat.com - April 15 at 4:39 PM
Radius Recycling (NASDAQ:RDUS)  Shares Down 6.9% Radius Recycling (NASDAQ:RDUS) Shares Down 6.9%
marketbeat.com - April 10 at 2:52 PM
Radius Health, Inc. (NASDAQ:RDUS) Q2 2024 Earnings Call TranscriptRadius Health, Inc. (NASDAQ:RDUS) Q2 2024 Earnings Call Transcript
finance.yahoo.com - April 8 at 9:35 AM
Radius Recycling (NASDAQ:RDUS) Is Due To Pay A Dividend Of $0.1875Radius Recycling (NASDAQ:RDUS) Is Due To Pay A Dividend Of $0.1875
uk.finance.yahoo.com - April 7 at 7:50 PM
Radius Recycling declares $0.1875 dividendRadius Recycling declares $0.1875 dividend
seekingalpha.com - April 6 at 2:11 PM
Radius Recycling (NASDAQ:RDUS) Downgraded by StockNews.comRadius Recycling (NASDAQ:RDUS) Downgraded by StockNews.com
marketbeat.com - April 5 at 11:10 PM
Radius Recycling, Inc. (RDUS) Q2 2024 Earnings Call TranscriptRadius Recycling, Inc. (RDUS) Q2 2024 Earnings Call Transcript
seekingalpha.com - April 5 at 10:55 PM
Radius Recycling Inc (RDUS) Q2 2024 Earnings Call Transcript Highlights: Strategic Adjustments ...Radius Recycling Inc (RDUS) Q2 2024 Earnings Call Transcript Highlights: Strategic Adjustments ...
finance.yahoo.com - April 5 at 5:55 PM
Radius Recycling, Inc. (NASDAQ:RDUS) Announces $0.19 Quarterly DividendRadius Recycling, Inc. (NASDAQ:RDUS) Announces $0.19 Quarterly Dividend
marketbeat.com - April 5 at 5:19 PM
Radius Recycling (NASDAQ:RDUS) Announces  Earnings ResultsRadius Recycling (NASDAQ:RDUS) Announces Earnings Results
marketbeat.com - April 5 at 8:23 AM
Radius Recycling Second Quarter 2024 Earnings: EPS Misses ExpectationsRadius Recycling Second Quarter 2024 Earnings: EPS Misses Expectations
finance.yahoo.com - April 5 at 7:50 AM
Radius Recycling Reports Q2 Results; American Battery Awarded Another $40.5 Million; Nexa Prices $600 Million Offering And More: Thursdays Top Mining StoriesRadius Recycling Reports Q2 Results; American Battery Awarded Another $40.5 Million; Nexa Prices $600 Million Offering And More: Thursday's Top Mining Stories
benzinga.com - April 4 at 6:02 PM
Radius Recycling (NASDAQ:RDUS) Hits New 12-Month Low at $17.04Radius Recycling (NASDAQ:RDUS) Hits New 12-Month Low at $17.04
marketbeat.com - April 4 at 1:20 PM
Radius Recycling, Inc. 2024 Q2 - Results - Earnings Call PresentationRadius Recycling, Inc. 2024 Q2 - Results - Earnings Call Presentation
seekingalpha.com - April 4 at 11:56 AM
Stocks Rise Before the Open as Investors Shift Focus to Key U.S. Jobs Data, ECB Minutes on TapStocks Rise Before the Open as Investors Shift Focus to Key U.S. Jobs Data, ECB Minutes on Tap
msn.com - April 4 at 10:59 AM
Radius Recycling: Fiscal Q2 Earnings SnapshotRadius Recycling: Fiscal Q2 Earnings Snapshot
finance.yahoo.com - April 4 at 10:59 AM
Radius Recycling Inc (RDUS) Misses Earnings Predictions with Q2 Fiscal 2024 ResultsRadius Recycling Inc (RDUS) Misses Earnings Predictions with Q2 Fiscal 2024 Results
finance.yahoo.com - April 4 at 10:59 AM
Radius Recycling Reports Second Quarter Fiscal 2024 Financial ResultsRadius Recycling Reports Second Quarter Fiscal 2024 Financial Results
globenewswire.com - April 4 at 8:00 AM
Recycling plant on Darrington Road on fireRecycling plant on Darrington Road on fire
kvia.com - March 28 at 12:29 PM
Analysts Estimate Radius Recycling (RDUS) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Radius Recycling (RDUS) to Report a Decline in Earnings: What to Look Out for
zacks.com - March 28 at 11:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Akouos logo

Akouos

NASDAQ:AKUS
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.
BioSpecifics Technologies logo

BioSpecifics Technologies

NASDAQ:BSTC
BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, human lipoma, and uterine fibroids. The company has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.
Eagle Pharmaceuticals logo

Eagle Pharmaceuticals

NASDAQ:EGRX
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Emisphere Technologies logo

Emisphere Technologies

OTCMKTS:EMIS
Emisphere Technologies, Inc. operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and pain, as well as in the development and expansion of nutritional supplement products. It has license agreements with Novo Nordisk A/S to develop and commercialize oral formulations of GLP-1 receptor agonists in combination with Emisphere carriers, as well as to develop and commercialize oral formulations of Novo Nordisk's insulin using the company's Eligen Technology. The company was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. Emisphere Technologies, Inc. was founded in 1986 and is based in Roseland, New Jersey.
Radius Recycling logo

Radius Recycling

NASDAQ:RDUS
Radius Recycling, Inc. recycles ferrous and nonferrous metal, and manufactures finished steel products worldwide. The company acquires, processes, and recycles salvaged vehicles, rail cars, home appliances, industrial machinery, manufacturing scrap, and construction and demolition scrap. It offers recycled ferrous metal, a feedstock used in the production of finished steel products; and nonferrous products, including mixed metal joint products recovered from the shredding process, such as zorba, zurik, aluminum, copper, stainless steel, nickel, brass, titanium, lead, and high temperature alloys. The company also procures salvaged vehicles and sells serviceable used auto parts from these vehicles through its retail self-service auto parts stores. In addition, it produces various finished steel products using ferrous recycled metal and other raw materials, as well as semi-finished goods, which include billets; and finished goods consisting of rebar, coiled rebar, wire rods, merchant bars, and other specialty products. Further, the company sells catalytic converters to specialty processors that extract the nonferrous precious metals, including platinum, palladium, and rhodium; and ferrous and nonferrous recycled metal products to steel mills, foundries, refineries, smelters, wholesalers, and recycled metal processors, as well as finished steel customers, such as steel service centers, construction industry subcontractors, steel fabricators, wire drawers, and major farm and wood products suppliers. It also provides recycling and related services, including scrap brokerage, certified destruction, automotive parts recycling, railcar dismantling, and reverse logistics under 3PR brand name. Radius Recycling, Inc. was formerly known as Schnitzer Steel Industries, Inc. and changed its name to Radius Recycling, Inc. in January 2024. Radius Recycling, Inc. was founded in 1906 and is headquartered in Portland, Oregon.